Maarten de Château M.D. Ph.D.

Board member since 2017

Dr Maarten de Château (1963) is currently CEO of Sixera Pharma and Buzzard Pharmaceuticals. He serves as chairman of the Board of Atrogi, and on the Boards of Cavis Technologies and Gesynta Pharma. Maarten was Co-founder and CEO of Cormorant Pharmaceuticals – a company that developed a therapeutic antibody approach in immuno-oncology that was acquired by Bristol-Myers Squibb in 2016. Prior to that, Maarten held the position of Medical Director at Swedish Orphan Biovitrum; he has also worked in clinical development at Sanofi and as an investment bank financial analyst for five years. Maarten holds a PhD and an MD from the University of Lund, Sweden.

Stay Updated

Sign up for the Beactica newsletter to receive our latest news and updates